BioSpace News Archive

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced plans to present an overview of the Company and provide a business update at the upcoming Solebury Trout Virtual Investor Conference.

Symago, a leading provider of Interactive Voice Response (IVR) solutions, announced today the entry of SymRx™, a complete IVR solution for pharmacies, into Epic’s App Orchard program.

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on competitive intelligence solution for a medical devices market client.

3Diligent today announced it will help to coordinate the response of 3D printer owners and other digital manufacturers to help ease the shortage of personal protective equipment (PPE) caused by the coronavirus, called COVID-19.

NetNoggin® analyzes big data to better understand where biotech and pharmaceutical companies stand in the NASH/NAFL market.

While many Americans are sheltering at home to help “flatten the curve” and slow the spread of coronavirus disease, they might be tempted to buy or use questionable products that claim to help diagnose, treat, cure, and even prevent COVID-19.

Conversational AI leader Avaamo announces today that it has released Project COVID, an Intelligent Virtual Assistant that leverages Avaamo’s Conversational AI and deep learning technologies to answer the public’s pressing questions on COVID-19

Today Berkeley Lights, Inc., announced the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) with founding members Dr. James Crowe and Dr. Robert Carnahan at Vanderbilt University Medical Center, Dr. Erica Ollman Saphire at La Jolla Institute for Immunology and Dr. Frances Eun-Hyung Lee at Emory University with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples

U.S.-based Brooklyn Bedding has announced it will repurpose its proprietary technology, developed 16 years ago to meet a desperate need in the trucking industry, to produce hospital beds in the face of the COVID-19 pandemic.

Researchers have found that early-life adversity can have long-term effects on people’s memory and thinking in later life.